During 3 years treatment of primary progressive multiple sclerosis with glatiramer acetate, specific antibodies switch from IgG1 to IgG4
Author:
Publisher
Elsevier BV
Subject
Neurology (clinical),Neurology,Immunology,Immunology and Allergy
Reference32 articles.
1. Copolymer 1 induces T cells of the T helper type 2 that cross-react with myelin basic protein and suppress experimental autoimmune encephalomyelitis;Aharoni;Proc. Natl. Acad. Sci. U. S. A.,1997
2. Bystander suppression of experimental autoimmune encephalomyelitis by T cell lines and clones of the Th2 type induced by copolymer 1;Aharoni;J. Neuroimmunol.,1998
3. Glatiramer acetate specific T cells in the brain express T helper 2/3 cytokines and brainderived neurotrophic factor in situ;Aharoni;Proc. Natl. Acad. Sci. U. S. A.,2003
4. Humoral and cellular immune responses to copolymer 1 in multiple sclerosis patients treated with Copaxone®;Brenner;J. Neuroimmunol.,2001
5. Glatiramer acetate induces a Th2-biased response and cross-reactivity with myelin basic protein;Chen;Mult. Scler.,2001
Cited by 35 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Antidrug Antibodies Against Biological Treatments for Multiple Sclerosis;CNS Drugs;2022-05-19
2. Characteristics of Anti-Contactin1 Antibody-Associated Autoimmune Nodopathies With Concomitant Membranous Nephropathy;Frontiers in Immunology;2021-10-05
3. Blood Culture–Negative Cardiovascular Infection in a Patient With Multiple Sclerosis;Open Forum Infectious Diseases;2019-10-01
4. A differential sex-specific pattern of IgG2 and IgG4 subclasses of anti-drug antibodies (ADAs) induced by glatiramer acetate in relapsing-remitting multiple sclerosis patients;Multiple Sclerosis and Related Disorders;2019-09
5. Induction of apoptosis in CD4(+) T-cells is linked with optimal treatment response in patients with relapsing-remitting multiple sclerosis treated with Glatiramer acetate;Journal of the Neurological Sciences;2019-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3